Sickle cell nephropathy
Introduction
Sickle cell disease (SCD) is a hematologic disorder characterized by erythrocytes that take a rigid sickle shape, decreasing the cells flexibility and causing a wide range of systemic complications. The disease is genetic and caused by a point mutation resulting in the replacement of hemoglobin A with the sickle prone hemoglobin S (HbS). The disease is passed down in an autosomal recessive pattern, with true SCD having a homozygous mutation and those with sickle cell trait being heterozygous. With increased awareness and treatment modalities, life expectancy of SCD patients has improved greatly over the past few decades, because of this, physicians must be more vigilant for the long-term complications of SCD.1, 2 The highly vascular nature of the kidney causes it to be a common victim of sickle cell damage. While one of the most devastating effects to monitor for is sickle cell-induced renal failure or sickle cell nephropathy (SCN), physicians must also be familiar with the other common renal manifestations of SCD.
Section snippets
Epidemiology
SCD affects anywhere from 70,000 to 100,000 people in the United States. It is seen most commonly in African Americans (1 out of 500 births), but can be found in a myriad of ethnicities including South American, Caribbean, Mediterranean, Indian, and Saudi Arabian. The sickle cell trait is even more common, being found in over 2 million Americans and 1 out of 12 African Americans.3 The protective nature of the disease leads to its higher prevalence in areas where malaria is endemic.
Renal
Pathophysiology
The inner medulla of the kidney provides an acidic environment with low oxygen tension and high osmolality. This seems to be ideal to promote polymerization of deoxygenated hemoglobin S and sickling of the erythrocytes.5 The chronic sickling leads to ischemic injury and microinfarcts that result in microvascular damage and extravasation of blood in the medulla. Severe occlusions result in renal infarcts and papillary necrosis.11
Glomerular hypoxia stimulates prostaglandin release and
Manifestations
There is a wide-ranging set of renal manifestations seen in SCD patients, from painless hematuria to progressive renal failure. The majority of these symptoms are seen more commonly in SCD patients rather than in those with sickle cell trait. The interesting exception is renal medullary carcinoma, which is more prominent in sickle cell trait.1 This deadly cancer is often metastatic at presentation, is found in patients younger than 20, and has a male predominance in childhood. It carries a
Diagnosis and early detection
Diagnosis of renal disease secondary to SCD is largely based on observed clinical manifestations. It is primarily a diagnosis of exclusion. Renal biopsy is not typically needed unless there is acute onset of massive proteinuria or unexplained rapidly progressive renal failure. When suspecting SCN, diagnostic workup should begin with urinalysis and quantification of total urinary protein. The overall renal function needs to be assessed.11 This is usually done by creatinine-based GFR
Differential diagnosis
It must be stressed that renal disease seen in a sickle cell patient should not be assumed to be SCN until more common causes have been ruled out. A comprehensive clinical, family, and social history should be obtained in order to formulate a full differential diagnosis. Some of the more common non-SCN causes of renal disease in sickle cell patients include acute tubular necrosis due to chronic ischemia and toxins, membranoproliferative glomerulonephritis due to hepatitis C, obstructive
Treatment
Hematuria is a common complication of SCN and often self-limited in nature. Conservative measures such as bed rest, to prevent dislodging of blood clots, and oral hydration are the preferred treatments. Severe cases have been treated with urine alkalinization, loop diuretics to increase urine flow, and blood transfusion to reduce the hemoglobin S concentration.11, 16 Refractory severe hematuria can be difficult to treat, and though many approaches have been attempted, none has been well
Prognosis
Survival is significantly decreased in sickle cell patients who develop renal failure. A study showed that sickle cell patients diagnosed with ESRD had an average survival rate of about 4 years after starting hemodialysis.5 Median survival rates of sickle cell patients with and without renal failure differ drastically at 29 and 51 years, respectively. The mortality risk that renal failure adds to a sickle cell patient is similar to the risk seen in patients who have had a stroke.11 There is
Summary
Among the many systemic complications associated with SCD, the renal system remains one of the most susceptible to a variety of sickle-induced insults. Microthrombotic infarctions of the vasa recta capillaries and extravasation of blood in the medulla are the precipitating factors for a myriad of renal manifestations ranging from simple hematuria to nephrotic range proteinuria and renal failure. Physicians should always be vigilant for signs of any renal complications. Once a suspicion of renal
References (22)
- et al.
Genitourinary complications of sickle cell disease
J Urol
(2001) - et al.
Renal medullary carcinoma: the Bronx experience
Urology
(2007) - et al.
Renal abnormalities in sickle cell disease
Kidney Int
(2000) - et al.
Sickle cell disease, nephrotic syndrome, and renal failure
Kidney Int
(2006) - et al.
Early markers of renal dysfunction in patients with sickle cell/beta-thalassemia
Kidney Int
(2006) - et al.
A randomized trial of captopril for microalbuminuria in normotensive adults with sickle cell anemia
Am J Med
(1998) - et al.
Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients
Medicine (Baltimore)
(2005) - National Heart, Lung, and Blood Institute. Disease and conditions index. Sickle cell anemia: who is at risk? Bethesda,...
- et al.
Outcome in hemoglobin SC disease: a four-decade observational study of clinical, hematologic, and genetic factors
Am J Hematol
(2002) - et al.
Sickle cell nephropathy—a practical approach
Br J Haematol
(2011)
Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme
N Engl J Med
Cited by (7)
Sickle cell nephropathy
2019, Nephrology Secrets: Fourth EditionPrevalence of urological complications associated with sickle cell disease
2019, Bahrain Medical BulletinSickle cell disease nephropathy: An update on risk factors and potential biomarkers in pediatric patients
2018, Biomarkers in MedicineIncreased prevalence of renal cysts in patients with sickle cell disease
2017, BMC NephrologyRenal complications of sickle cell syndrome in southern Iran
2017, Iranian Journal of Pediatrics